Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
18 authors.
John M NesemannFrancis I Proctor Foundation, University of California San Francisco, San Francisco, California, USA.ORCID 0000-0002-9948-6498
Noelia Morocho-AlburquequeEmerge, Emerging Diseases and Climate Change Research Unit, School of Public Health and Administration, Universidad Peruana Cayetano Heredia, Lima, Peru.ORCID 0000-0002-2286-7022
Alvaro Quincho-LopezEmerge, Emerging Diseases and Climate Change Research Unit, School of Public Health and Administration, Universidad Peruana Cayetano Heredia, Lima, Peru.ORCID 0000-0003-3556-0086
Dionna M WittbergFrancis I Proctor Foundation, University of California San Francisco, San Francisco, California, USA.ORCID 0000-0002-9887-5993
Harvy A Honorio-MoralesCentro de Salud Ocular, Ministerio de Salud, Lima, Peru.ORCID 0000-0003-2661-9971
Salomón DurandÁrea de Epidemiología, Dirección Regional de Salud Loreto, Iquitos, Peru.ORCID 0000-0002-5923-8879
Martha Idalí Saboyá-DíazCommunicable Diseases Prevention, Control, and Elimination Department, Pan American Health Organization, Washington D.C., USA.ORCID 0000-0003-4324-9618
Silver K VargasCentro de Investigación Interdisciplinaria en Sexualidad SIDA y Sociedad, Universidad Peruana Cayetano Heredia, Lima, Peru.ORCID 0000-0002-8188-9598
Fisseha AdmassuDepartment of Ophthalmology, University of Gondar, Gondar, Ethiopia.ORCID 0000-0001-6139-5980
Ana BakthiariInternational Trachoma Initiative, Task Force for Global Health, Decatur, Georgia, USA.ORCID 0000-0003-4083-7115
Cristina JimenezTropical Data Programme, Sightsavers, Haywards Heath, United Kingdom.
Emma M Harding-EschClinical Research Department, London School of Hygiene and Tropical Medicine, London, United Kingdom.ORCID 0000-0002-1432-8109
Sandra L TaleroCommunicable Diseases Prevention, Control, and Elimination Department, Pan American Health Organization, Washington D.C., USA.ORCID 0000-0002-0494-2017
Marlene MuñozDepartmento de Epidemiologia, Red de Salud Alto Amazonas, Yurimaguas, Peru.
Anthony W SolomonGlobal Neglected Tropical Diseases Programme, World Health Organization, Geneva, Switzerland.ORCID 0000-0001-7101-6649
Jeffrey D KlausnerDivision of Disease Prevention, Policy and Global Health, Department of Preventive Medicine, University of Southern California Keck School of Medicine, Los Angeles, California, USA.
Andres G LescanoEmerge, Emerging Diseases and Climate Change Research Unit, School of Public Health and Administration, Universidad Peruana Cayetano Heredia, Lima, Peru.ORCID 0000-0001-9779-633X
Jeremy D KeenanFrancis I Proctor Foundation, University of California San Francisco, San Francisco, California, USA.ORCID 0000-0002-7118-1457
Funding
University of California Launching Future Leaders in Global Health Research Training ProgramD43TW009343 · FIC · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CRAIG R COHEN, Sung-Jae Lee · 2017 to 2026
$14.7M
Peru Infectious Diseases Epidemiology Research Training ConsortiumD43TW007393 · FIC · UNIVERSIDAD PERUANA CAYETANO HEREDIA · PI Andres G Lescano · 2005 to 2026
$5.9M
Integrating smartphone photography for trachoma, smartphone visual acuity assessment, and mobile autorefraction to enhance community-based public health monitoring - Diversity SupplementR33EY033690 · NEI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Jeremy David Keenan · 2023 to 2026
$1.0M
Integrating smartphone photography for trachoma, smartphone visual acuity assessment, and mobile autorefraction to enhance community-based public health monitoringR21EY033690 · NEI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KEENAN, JEREMY DAVID, LESCANO, ANDRES G · 2021 to 2022
backgroundTrachoma mapping in Latin America is incomplete, especially in indigenous communities of the Amazon thought to be at highest risk. The aim of this study was to determine the prevalence of clinical, microbiological, and serologic evidence of trachoma in a remote area of the Peruvian Amazon.
methodsA population-based sample of households from rural communities in Alto Amazonas province was selected using 2-stage cluster sampling. In children aged 1-9 years, conjunctival photographs, conjunctival swabs, and dried blood spots were collected. Photographs were graded for trachomatous inflammation-follicular (TF). Swabs were processed for Chlamydia trachomatis with a nucleic acid amplification test. Dried blood spots were assessed for antibody responses to C. trachomatis with a multiplex bead assay.
resultsA total of 778 children aged 1-9 years from 21 communities participated. The age-adjusted prevalence of TF among 1-9-year-old children was 25.4% (95% CI 21.3%-29.5%), compared with 0.8% (95% CI 0.5%-1.0%) for ocular C. trachomatis and 6.6% (95% CI 4.5%-9.0%) for Pgp3-specific antibodies to C. trachomatis.
conclusionsThis region of the Peruvian Amazon had a high burden of clinical trachoma but low levels of C. trachomatis ocular infection and seropositivity.
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Discrepancy Between Active Trachoma and Tests of Chlamydial Infection in Alto Amazonas, Peru. · full record | OpenQuestion